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Methods of urinary iodine measurements 
 
In Generation R, urinary iodine was measured by the Sandell-Kolthoff method. Iodine calibration was performed using certified reference 
materials (CRM) Seronorm urine Levels one and two (Nycomed, Norway), and four EQUIP samples certified for urinary iodine 
concentration (Centers for Disease Control and Prevention, USA). At a level of 1.7 µmol/l iodine the within-assay CV was 5.1% and the 
between-assay CV was 14.3% (n= 30). In INMA, urinary iodine was measured using paired-ion reversed-phase, high-performance liquid 
chromatography (HPLC) with electrochemical detection at a silver working electrode (Waters Chromatography, Milford, MA). The 
accuracy of the results was verified using the CRM Seronorm urine Levels one and two (Nycomed, Norway), and internal quality control 
samples. Within run precision was 4.5% relative standard deviation (RSD) at 50 μg/L, 3.2% at 100 μg/L and 2.0% at 300 μg/L. Between 
run precision was 7.9% RSD at 50 μg/L, 3.5% at 100 μg/L and 2.5 % at 300 μg/L. In ALSPAC, iodine (127I) was measured on a dynamic 
reaction cell inductively-coupled plasma (ICP) mass spectrometer. The accuracy of the results was verified using the CRM Seronorm 
urine Levels one and two (Nycomed, Norway), and accuracy was also monitored by measurement of EQUIP samples at regular intervals 
throughout the analysis. Within run precision was 0.83% RSD at 42 µg/L, 2.47% at 84 µg/L, 0.56% at 149 µg/L and 2.01% at 297 µg/L. 
Between run precision was 8.69% RSD at 42 µg/L, 6.54% at 84 µg/L, 7.2% at 149 µg/L and 6.8% at 297 µg/L. 
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eTable 1 Distribution and comparison of maternal and child characteristics in the included and excluded 
population 
 
Generation R INMA ALSPAC 
 included       
(n=1931) 
not included 
(n=7818) 
P-value 
Included     
(n=1269) 
not included 
(n=881) 
P-value 
Included   
(n=2980) 
not included 
(n=11752) 
P-value 
Female sex, n(%) 963 (49.9) 3846 (49.2) 0.605 632 (49.8) 348 (46.5) 0.150 1514 (50.8) 5312 (47.6) 0.002 
Educational level, n(%)                  
    Low 154 (8.4) 791 (12.0) 
<0.001 
270 (21.3) 293 (34.4) 
<0.001 
573 (19.8) 3183 (33.1) 
<0.001     Middle 760 (41.4) 3117 (47.2) 525 (41.5) 337 (39.6) 1810 (62.7) 5318 (55.4) 
    High 921 (50.2) 2692 (40.8) 470 (37.2) 221 (26.0) 505 (17.5) 1104 (11.5) 
Maternal 
ethnicity/country of 
birth, n(%)      
 
    
 
    
 
    Spanish NA NA  
 
 
 
 
0.001 
1184 (93.5) 731 (85.8) 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
NA NA  
 
 
 
<0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Latin-american NA NA 56 (4.4) 80 (9.4) NA NA 
    European/other NA NA 26 (2.1) 41 (4.8) NA NA 
    Dutch 1012 (53.2) 3490  (49.5) NA NA NA NA 
    Indonesian 69 (3.6) 198 (2.8) NA NA NA NA 
    Cape verdian 58 (3.1) 314 (4.5) NA NA NA NA 
    Moroccan 115 (6.0) 487 (6.9) NA NA NA NA 
    Surinamese 154 (8.1) 636 (9.0) NA NA NA NA 
    Turkish 170 (9.0) 617 (8.7) NA NA NA NA 
    Other, non-western   150 (7.9) 724 (10.3) NA NA NA NA 
    Other, western 174 (9.1) 589 (8.3) NA NA NA NA 
    White NA NA NA NA 2841 (98.7) 9234 (97.0) 
    Non-white NA NA NA NA 36 (1.3) 290 (3.0) 
Maternal age, years, 
mean (SD) 
30.5 (4.8) 29.8 (5.5) <0.001 31.6 (3.9) 30.7 (4.8) <0.001 28.6 (4.5) 26.9 (5.1) <0.001 
Parity, n(%)           
   0 1121 (58.1) 3986 (51.8) 
<0.001 
 
727 (57.4) 441 (51.8) 
0.018 
1346 (46.8) 4527 (44.2) 
0.018    1 564 (29.2) 2231 (29.0) 458 (36.1) 335 (39.4) 992 (34.5) 3596 (35.1) 
   ≥2 246 (12.7) 1480 (19.2) 82 (6.5) 75 (8.8) 539 (18.7) 2124 (20.7) 
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eTable 1 Distribution and comparison of maternal and child characteristics in the included and excluded population (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Generation R INMA ALSPAC 
 included       
(n=1931) 
not included 
(n=7818) 
P-value 
Included     
(n=1269) 
not included 
(n=881) 
P-value 
Included   
(n=2980) 
not included 
(n=11752) 
P-value 
Smoking during 
pregnancy , n(%) 
      
  
 
   Never 1319 (75.6) 4648 (72.9) 
<0.001 
 
870 (69.4) 478 (64.2) 
0.055 
2434 (83.2) 7446 (71.4) 
<0.001 
   In the beginning of 
   pregnancy 
168 (9.6) 523 (8.2) 168 (13.4) 116 (15.6) 125 (4.3) 682 (6.5) 
   Continued  257 (14.7) 1208 (18.9) 216 (17.2) 151 (20.3) 367 (12.5) 2305 (22.1) 
Pre-pregnancy BMI, 
kg/m
2
, median (IQR) 
22.6 (20.8-25.2) 22.6 (20.7-25.5) 0.926 22.5 (20.8-25.0) 22.6 (20.7-25.3) 0.670 22.2 (20.5-24.4) 22.1 (20.4-24.4) 0.077 
 
P-value for differences calculated using Chi-square test for categorical variables, Student´s t‐test for continuous normal‐distributed variables, and Kruskal‐Wallis test for continuous non‐normal distributed variables. NA: 
not applicable.  Numbers are based on unimputed data; percentages add up to 100% without taking into account missing values. 
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eTable 2 Continuous analysis of the association of maternal iodine status during 
pregnancy with child non-verbal and verbal IQ using standard linear regression 
models. 
 
  
Non-verbal IQ verbal IQ 
Type of model 
Variables in the 
model  
Beta (95%CI) P-value Beta (95%CI) P-value 
linear model UI/Creat 0.602 (-0.007 to 1.210) 0.053 1.061 (0.450 to 1.672) 0.001 
non-linear model 
UI/Creat 0.632 (-5.848 to 7.113) 0.848 10.011 (3.499 to 16.523) 0.003 
UI/Creat^2 -0.003 (-0.651 to 0.644) 0.993 -0.898 (-1.549 to -0.247) 0.007 
 
Reported beta and 95%CI are increase in mean child IQ per natural log increase in UI/Creat. UI/Creat^2 refers to the addition of a 
squared logtransformed UI/Creat variable in the model. Analyses were performed using linear regression models. Analyses were 
adjusted for gestational age at urine sampling, child sex, maternal ethnicity/country of birth, maternal education, parity, maternal age, 
pre-pregnancy BMI, and smoking during pregnancy. 
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eFigure 1  Association of UI/Creat < 150 µg/g and UI/Creat ≥ 500 µg/g during 
pregnancy with child suboptimal non-verbal and verbal IQ.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
eFigure 1 Association of UI/Creat < 150 µg/g and UI/Creat ≥ 500 µg/g during pregnancy with 
child suboptimal non-verbal and verbal IQ.  
Figure shows the association of UI/Creat <150 µg/g (“deficiency”) with a) non-verbal IQ score <85 and c) verbal IQ score 
<85, and UI/Creat >=500 µg/g (“excess”) with b) non-verbal IQ score <85 and d) verbal IQ score <85 as compared to the 
reference group (UI/Creat ≥150 to <500 µg/g). Associations are depicted as effect estimate (dot) with 95%CI per cohort 
and overall as estimated by random-effects meta-analysis (diamond). Models are adjusted for gestational age, child sex, 
maternal ethnicity/country of birth, maternal education, parity, maternal age, pre-pregnancy BMI, smoking during 
pregnancy, child age and region in INMA.  
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eTable 3 Continuous analysis of the association of maternal iodine status during 
pregnancy with child verbal IQ stratified by tertile of gestational age using 
standard linear regression models. 
 
 
Reported beta and 95%CI are increase in mean child verbal IQ per log increase in UI/Creat. UI/Creat^2 refers to the addition of a 
squared UI/Creat variable in the model. Analyses were performed using linear regression models. UI/Creat was transformed by the 
natural logarithm. Analyses were adjusted for gestational age at urine sampling, child sex, maternal ethnicity/country of birth, 
maternal education, parity, maternal age, pre-pregnancy BMI, and smoking during pregnancy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Type of model 
Variables in the 
model 
Gestational 
age (weeks) 
Beta (95%CI) P-value 
non-linear model 
UI/Creat 
≤12 
18.276 (6.923 to 29.628) 0.002 
UI/Creat^2 -1.786 (-2.953 to -0.620) 0.003 
Linear model  UI/Creat >12 and ≤14 1.333 (0.230 to 2.436) 0.018 
Linear model UI/Creat >14 0.444 (-0.601 to 1.489) 0.405 
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 eTable 4  Comparison of the ALSPAC study population included in the current study and in the previous publication of Bath et 
al. 2013  
 
  
 
this study cohort 
this study cohort restricted to 
≤13 weeks gestation 
Bath et al. 2013 
No. 2980 1845 958 
gestational age, median (IQR) 12 (8-16) 9 (7-11) 10 (9-12) 
UI/Creat, µg/g, median (IQR) 124 (82-199) 108 (75-161) 110 (74-170) 
UI/Creat < 150 µg/g , % 61.4 70.1 67.4 
UIC, µg/L, median (IQR) 96 (57-153) 96.8 (60-149) 91.1 (53.8-143) 
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eTable 5  Association of maternal iodine status with a child verbal IQ score in the lowest quartile as studied in the current ALSPAC study population and 
as in the previous publication of Bath et al. 2013  
 
 
this study cohort 
 
[OR (95%CI), P-value] 
this study cohort restricted  
to  ≤13 weeks gestation                
[OR (95%CI), P-value] 
Bath et al. 2013                                    
 
[OR (95%CI), P-value] 
1.13 (0.92 to 1.39), 0.259 1.42 (1.06 to 1.91), 0.019 1.58 (1.09 to 2.30), 0.02 
 
Reported OR and 95%CI for a verbal IQ score in the bottom quartile when exposed to a maternal UI/Creat < 150 µg/g vs ≥ 150 µg/g (reference group) during pregnancy. Analyses with un-imputed data were 
performed using logistic regression models and were adjusted as similarly as possible as compared to the fully adjusted model (model 3) as reported in the publication of Bath et al.  Analyses were adjusted 
for preterm birth, birthweight, child sex, maternal education, paternal education, maternal ethnicity (instead of child ethnicity), parity, age at delivery, smoking, maternal alcohol intake, breastfeeding, iron 
intake, and omega-3 fatty acid intake estimated from the Food Frequency Questionnaire completed at 32 weeks’ of gestation. Missing information that was corrected for in model 3 of Bath et al but lacking in 
the analysis of this study cohort, were: mothers parenting score (seven-factor measure of cognitive stimulation at 6 months of age), home observation for measurement of environment (HOME) score (six-
factor measure of the emotional and cognitive environment at 6 months of age), the family adversity index (18-factor measure of hardship during pregnancy), life-event score (exposure to 41 stressful events 
during pregnancy), maternal depression since birth, fish-oil supplements during pregnancy, housing status, and crowding.  
 
 
 
